High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression

Citation
A. Neumann et al., High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression, FEBS LETTER, 453(3), 1999, pp. 283-287
Citations number
34
Categorie Soggetti
Biochemistry & Biophysics
Journal title
FEBS LETTERS
ISSN journal
00145793 → ACNP
Volume
453
Issue
3
Year of publication
1999
Pages
283 - 287
Database
ISI
SICI code
0014-5793(19990625)453:3<283:HMWHAI>2.0.ZU;2-0
Abstract
Advanced glycation endproducts (AGEs), which accumulate on long-lived prote ins and protein deposits (amyloids), induce the expression of proinflammato ry cytokines through NF-kappa B-dependent pathways. Hyaluronic acid with a molecular weight above 1.2 MDa (HMW-HA) inhibits the AGE-induced activation of the transcription factor NF-kappa B and the NF-kappa B-regulated cytoki nes interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha. Sin ce the molecular weight of hyaluronic acid in humans decreases,vith age and under conditions of oxidative stress, it is likely that the protective eff ect of HMW-HA against AGE-induced cellular activation is lost at sites of c hronic inflammation and in older age. (C) 1999 Federation of European Bioch emical Societies.